source
- Allen Institute launches multi-hundred-million-dollar effort to turn brain atlas data into neurodegenerative drug candidatesThe Allen Institute, a Seattle nonprofit known for basic brain research, announced a major new effort to move its brain‑atlas knowledge toward drug development. The program will invest several hun…
- FDA issues draft guidance outlining data flexibilities for cell and gene therapy developersThe FDA released a draft guidance from its Center for Biologics Evaluation and Research (CBER) that clarifies how developers of cell and gene therapies can use existing data and prior knowledge in…